Positional isomers of acetaminophen differentially induce proliferation of cultured breast cancer cells

被引:7
作者
Harnagea-Theophilus, E
Miller, MR
Rao, N
机构
[1] W Virginia Univ, Dept Biochem, RC Byrd Hlth Sci Ctr, Morgantown, WV 26506 USA
[2] W Virginia Univ, Dept Pharmacol & Toxicol, RC Byrd Hlth Sci Ctr, Morgantown, WV 26506 USA
[3] NIOSH, CDC, Morgantown, WV 26505 USA
关键词
acetaminophen/paracetamol; breast cancer cells; isomers; proliferation;
D O I
10.1016/S0378-4274(98)00227-6
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
This study demonstrates that acetaminophen (p-acetamidophenol) stimulates proliferation of estrogen-responsive cultured breast cancer cells and assesses if the proliferative activity of p-acetamidophenol is influenced by the -OH moiety position on the benzene ring. The effects of p-, m-, and o-acetamidophenol on cell number and on percentage cells in S phase of the cell cycle were determined for two estrogen receptor positive, human breast cancer cell lines, T47D and MCF7. Therapeutic concentrations of p-acetamidophenol (0.1 mM) significantly increased breast cancer cell proliferation. The relative order of potency of isomers in stimulating proliferation in both cell types was p- > m- > o-acetamidophenol, indicating the -OH position on the benzene ring influences the proliferation output in cultured breast cancer cells. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:11 / 18
页数:8
相关论文
共 22 条
  • [1] BOYD EM, 1970, J CLIN PHARMACOL N D, V10, P222
  • [2] Human breast cancer cell line xenografts as models of breast cancer - The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines
    Clarke, R
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1996, 39 (01) : 69 - 86
  • [3] CLARKE R, 1995, DIS BREAST, P245
  • [4] Over-the-counter analgesics and risk of ovarian cancer
    Cramer, DW
    Harlow, BL
    Titus-Ernstoff, L
    Bohlke, K
    Welch, WR
    Greenberg, ER
    [J]. LANCET, 1998, 351 (9096) : 104 - 107
  • [5] A dichotomy in the lipophilicity of natural estrogens, xenoestrogens, and phytoestrogens
    Cunningham, AR
    Klopman, G
    Rosenkranz, HS
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 1997, 105 : 665 - 668
  • [6] DABRE P, 1983, CANCER RES, V43, P349
  • [7] CLINICAL PHARMACOKINETICS OF PARACETAMOL
    FORREST, JAH
    CLEMENTS, JA
    PRESCOTT, LF
    [J]. CLINICAL PHARMACOKINETICS, 1982, 7 (02) : 93 - 107
  • [8] Haney A F, 1987, Reprod Toxicol, V1, P285, DOI 10.1016/0890-6238(87)90020-7
  • [9] HARNAGEATHEOPHI.E, 1998, IN PRESS TOXICOL SCI
  • [10] *IARC, IARC MON, V50, P307